In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams. 

MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences.

This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com.

We’ll also hear a message from regulatory firm MedTech Impact Partners.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

How Dohadwala uses analytics, her gut, and the benefits of diversity to build a strong VC portfolio

In this episode of the DeviceTalks Weekly Podcast, the DeviceTalks team wraps up the two amazing days of insights and networking at DeviceTalks West.

Tom Salemi, Kayleen Brown and Chris Newmarker welcome guests Alexis Moores, Senior Account Manager, and Steven Thill, Senior Director of Infor, which announced a partnership with NVIDIA at DeviceTalks West, the culmination of a connection forged at DeviceTalks Boston!

Thank you to Infor for sponsoring this episode of DeviceTalks Weekly. To learn how Infor supports MedTech companies visit www.infor.com.

The panel covers a few of the highlights from the event discussion surgical robotics, AI, interventional tools, women’s health.

But first, we unpack the details of PUMPKINGATE!

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Hear the final word about DeviceTalks West: Live recording of DeviceTalks Weekly on-stage

In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series. 

Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.

This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.

This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Phagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCs

In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology.

Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/

MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mind

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company’s strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company’s connectivity capabilities, response to wearable technology, and its take on a rival’s recall.

This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more.

We’ll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast player.

CEO Mick Farrell on how ResMed keeps on the leading edge of innovation; Our 2024’s Top Newsmakers

In this episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that’s approaching the complicated and competitive TAVR market.

Chris Newsmaker and Host Tom Salemi also discuss this week’s Newmarker’s Newsmakers including Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace and the FDA.

This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How an artful pivot and IPO is positioning Anteris Technologies to take on the red hot TAVR space

In this episode of the DeviceTalks Weekly Podcast, it’s a DeviceTalks Team Up. Editorial Director Tom Salemi and Managing Editor Kayleen Brown interview Doug Evans, CEO and President of Lungpacer Medical. Evans shares the tragic reason he vowed to start a company that would help wean patients off ventilators. We’ll hear his success story in the podcast, but join us at DeviceTalks Boston to hear the story behind the AeroPace technologies as Evans will be joined by Lungpacer COO Viral Thakkar and Mike Longo, vice president of product development.

Register to attend DeviceTalks Boston at Boston.DeviceTalks.com. If you missed our early bird rate use the code mentioned in the podcast on March 1 and 2.

Before the DeepDive conversation, we’ll have Mass Device Honcho Chris Newmarker’s Newsmakers - Medtronic, Solventum, FDA layoffs, Boston Scientific, and Teleflex.  

Jim Hammerand, managing editor of Medical Design & Outsourcing, opens with an overview of the magazine’s current Min-Vasive issue. You can find all the articles mentioned at medicaldesignandoutsourcing.com.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Hear Part 1 of Lungpacer Medical’s AeroPace Story; Be part of the conclusion at DeviceTalks Boston

In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers.

But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies.

You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.

Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely.

But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.

Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics.

Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

Popular tracks tagged #devicetalks weekly